Disease and treatment characteristics of participants (n=1436)
| Variable | Total (n=1436) n (%) |
| Diabetes duration | |
| <5 years | 292 (20.3) |
| 5–10 years | 390 (27.2) |
| >10 years | 754 (52.5) |
| Under injectable therapy | 273 (19.0) |
| Insulin only | 231 (16.1) |
| GLP-1 analogues only | 28 (1.9) |
| Both GLP-1 analogues and insulin | 14 (1.0) |
| Duration of injectable therapy | |
| <5 years | 114 (8.0) |
| 5–10 years | 76 (5.3) |
| >10 years | 83 (5.8) |
GLP-1, glucagon-like peptide-1.